Cumberland Pharmaceuticals Share Price Today
(NASDAQ: CPIX)

Name: Cumberland Pharmaceuticals Share Price Today (NASDAQ: CPIX) - Cumberland Pharmaceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Cumberland Pharmaceuticals share price is $6.77 & ₹588.78 as on 6 Mar 2025, 2.30 'hrs' IST

$6.77

▲

0.72

(11.9%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Cumberland Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Cumberland Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cumberland Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Cumberland Pharmaceuticals share price movements

Today's Low: $5.64
Today's High: $7.20
$6.77
16.69%
Downside
Day's Volatility :21.67%
Upside
5.97%
52 Weeks Low: $1.04
52 Weeks High: $7.25
$6.77
84.64%
Downside
52 Weeks Volatility :85.66%
Upside
6.62%

Cumberland Pharmaceuticals (CPIX) Returns

Period	Cumberland Pharmaceuticals Inc	Index (Russel 2000)
3 Months	473.73%	0.0%
6 Months	416.79%	0.0%
1 Year	248.97%	0.0%
3 Years	127.95%	-11.6%

Cumberland Pharmaceuticals (CPIX) Key Statistics

in dollars & INR

Previous Close	$6.05
Open	$5.75
Today's High	$7.2
Today's Low	$5.64
Market Capitalization	$85.0M
Today's Volume	$719.9K
52 Week High	$7.25
52 Week Low	$1.04
Revenue TTM	$36.8M
EBITDA	$-2.8M
Earnings Per Share (EPS)	$-0.92
Profit Margin	-29.55%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-36.07%

How to invest in Cumberland Pharmaceuticals Stock (CPIX) from India?

It is very easy for Indian residents to invest directly in Cumberland Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cumberland Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cumberland Pharmaceuticals or CPIX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cumberland Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cumberland Pharmaceuticals shares which would translate to 0.128 fractional shares of Cumberland Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cumberland Pharmaceuticals, in just a few clicks!

Returns in Cumberland Pharmaceuticals (CPIX) for Indian investors in Rupees

The Cumberland Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Cumberland Pharmaceuticals investment value today

Current value as on today

₹3,53,918

Returns

₹2,53,918

(+253.92%)

Returns from Cumberland Pharmaceuticals Stock

₹2,48,969 (+248.97%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Cumberland Pharmaceuticals (CPIX)

1660%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cumberland Pharmaceuticals Stock from India on INDmoney has increased by 1660% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Cumberland Pharmaceuticals

Renaissance Technologies Corp
3.61%
Vanguard Group Inc
2.67%
Dimensional Fund Advisors, Inc.
1.94%
Bridgeway Capital Management, LLC
1.31%
Bank of New York Mellon Corp
0.54%
Geode Capital Management, LLC
0.53%

Analyst Recommendation on Cumberland Pharmaceuticals

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Cumberland Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Cumberland Pharmaceuticals Stock (CPIX)

What analysts predicted

Upside of 25.55%

Target:

$8.50

Current:

$6.77

Insights on Cumberland Pharmaceuticals Stock (Ticker Symbol: CPIX)

Price Movement
In the last 7 days, CPIX stock has moved up by 36.2%
Decreasing Revenue
Revenue is down for the last 2 quarters, 9.84M → 9.08M (in $), with an average decrease of 7.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -1.08M → -1.54M (in $), with an average decrease of 42.2% per quarter
CPIX vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 138.1% return, outperforming this stock by 23.9%

CPIX Cumberland Pharmaceuticals Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$40.7M	↓ 0.99%
Net Income	$-7.0M	↓ 12.73%
Net Profit Margin	-17.09%	↑ 2.3%

	FY19	Y/Y Change
Revenue	$34.4M	↓ 15.59%
Net Income	$-9.2M	↑ 32.29%
Net Profit Margin	-26.79%	↓ 9.7%

	FY20	Y/Y Change
Revenue	$37.4M	↑ 8.88%
Net Income	$-6.6M	↓ 28.07%
Net Profit Margin	-17.7%	↑ 9.09%

	FY21	Y/Y Change
Revenue	$36.0M	↓ 3.89%
Net Income	$-5.6M	↓ 15.53%
Net Profit Margin	-15.55%	↑ 2.15%

	FY22	Y/Y Change
Revenue	$42.0M	↑ 16.75%
Net Income	$-5.7M	↑ 0.95%
Net Profit Margin	-13.45%	↑ 2.1%

	FY23	Y/Y Change
Revenue	$39.6M	↓ 5.85%
Net Income	$-6.3M	↑ 11.14%
Net Profit Margin	-15.88%	↓ 2.43%

	Q2 FY23	Q/Q Change
Revenue	$10.9M	↑ 18.04%
Net Income	$872.2K	↑ 353.84%
Net Profit Margin	8.01%	↑ 5.93%

	Q3 FY23	Q/Q Change
Revenue	$10.1M	↓ 7.37%
Net Income	$-1.0M	↓ 220.3%
Net Profit Margin	-10.4%	↓ 18.41%

	Q4 FY23	Q/Q Change
Revenue	$9.4M	↓ 7.27%
Net Income	$-6.3M	↑ 499.55%
Net Profit Margin	-67.26%	↓ 56.86%

	Q1 FY24	Q/Q Change
Revenue	$8.5M	↓ 9.15%
Net Income	$-1.9M	↓ 69.06%
Net Profit Margin	-22.9%	↑ 44.36%

	Q2 FY24	Q/Q Change
Revenue	$9.8M	↑ 15.9%
Net Income	$-1.1M	↓ 44.22%
Net Profit Margin	-11.02%	↑ 11.88%

	Q3 FY24	Q/Q Change
Revenue	$9.1M	↓ 7.75%
Net Income	$-1.5M	↑ 42.23%
Net Profit Margin	-16.99%	↓ 5.97%

	FY18	Y/Y Change
Profit	$33.4M	↓ 1.23%

	FY19	Y/Y Change
Profit	$27.0M	↓ 19.17%

	FY20	Y/Y Change
Profit	$28.8M	↑ 6.75%

	FY21	Y/Y Change
Profit	$27.2M	↓ 5.61%

	FY22	Y/Y Change
Profit	$32.9M	↑ 21.04%

	FY23	Y/Y Change
Profit	$33.5M	↑ 1.8%

	Q2 FY23	Q/Q Change
Profit	$9.4M	↑ 17.48%

	Q3 FY23	Q/Q Change
Profit	$8.3M	↓ 11.18%

	Q4 FY23	Q/Q Change
Profit	$6.6M	↓ 20.34%

	Q1 FY24	Q/Q Change
Profit	$5.8M	↓ 12.92%

	Q2 FY24	Q/Q Change
Profit	$7.0M	↑ 21.26%

	Q3 FY24	Q/Q Change
Profit	$7.8M	↑ 10.92%

	FY18	Y/Y Change
Operating Cash Flow	$3.1M	↓ 658.12%
Investing Cash Flow	$-27.7M	↓ 391.45%
Financing Cash Flow	$7.1M	↑ 266.5%

	FY19	Y/Y Change
Operating Cash Flow	$3.1M	↓ 1.81%
Investing Cash Flow	$2.3M	↓ 108.29%
Financing Cash Flow	$-5.1M	↓ 171.17%

	FY20	Y/Y Change
Operating Cash Flow	$5.4M	↑ 77.17%
Investing Cash Flow	$-1.8M	↓ 176.5%
Financing Cash Flow	$-7.1M	↑ 40.07%

	FY21	Y/Y Change
Operating Cash Flow	$6.3M	↑ 17.13%
Investing Cash Flow	$-501.9K	↓ 71.45%
Financing Cash Flow	$-3.6M	↓ 50.06%

	FY22	Y/Y Change
Operating Cash Flow	$8.5M	↑ 33.28%
Investing Cash Flow	$-13.7M	↑ 2624.58%
Financing Cash Flow	$-2.1M	↓ 41.98%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$5.2M	↓ 469.15%
Investing Cash Flow	$-96.8K	↑ 0.0%
Financing Cash Flow	$-3.3M	↑ 84.11%

Cumberland Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Cumberland Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Cumberland Pharmaceuticals (CPIX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cumberland Pharmaceuticals Inc	80.05%	416.79%	248.97%	127.95%	57.44%
Intra-cellular Therapies, Inc.	3.38%	81.15%	98.68%	146.46%	588.66%
Haleon Plc Spon Ads	10.71%	2.13%	26.53%	42.24%	42.24%
Zoetis Inc.	-3.04%	-10.5%	-9.01%	-11.21%	28.74%
Neurocrine Biosciences Inc.	-25.31%	-6.07%	-13.91%	29.45%	28.72%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cumberland Pharmaceuticals Inc	NA	NA	0.0	0.0	-0.36	-0.06	NA	1.77
Intra-cellular Therapies, Inc.	NA	NA	0.0	0.13	-0.09	-0.07	NA	10.81
Haleon Plc Spon Ads	26.35	26.35	1.92	0.36	0.09	0.04	0.02	1.8
Zoetis Inc.	31.17	31.17	3.01	6.07	0.51	0.15	0.01	10.64
Neurocrine Biosciences Inc.	34.6	34.6	0.27	6.44	0.14	0.1	NA	26.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cumberland Pharmaceuticals Inc	Sell	$85.0M	57.44%	NA	-29.55%
Intra-cellular Therapies, Inc.	Buy	$14.0B	588.66%	NA	-10.97%
Haleon Plc Spon Ads	Buy	$47.7B	42.24%	26.35	12.84%
Zoetis Inc.	Buy	$76.1B	28.74%	31.17	26.86%
Neurocrine Biosciences Inc.	Buy	$11.4B	28.72%	34.6	14.49%

About Cumberland Pharmaceuticals

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Organization	Cumberland Pharmaceuticals
Employees	91
CEO	Mr. A. J. Kazimi MBA
Industry	Health Technology

Management People of Cumberland Pharmaceuticals

Name	Title
Mr. A. J. Kazimi MBA	Founder, Chairman, President & CEO
Mr. John Michael Hamm C.M.A.	VP & CFO
Mr. James Lowrance Herman	Executive VP of National Accounts & Chief Compliance Officer
Mr. Chris T. Bitterman	Vice President of Sales & Marketing
Ms. Jean W. Marstiller	Senior VP of Administrative Services & Corporate Secretary
Mr. Adam S. Mostafa	Managing Director of Banking & Investor Relations
Ms. Erin Smith Gull	Senior Corporate Relations Associate

Important FAQs about investing in CPIX Stock from India :

What is Cumberland Pharmaceuticals share price today?

Cumberland Pharmaceuticals share price today stands at $6.77, Open: $5.75 ; Previous Close: $6.05 ; High: $7.20 ; Low: $5.64 ; 52 Week High: $7.25 ; 52 Week Low: $1.04.

The stock opens at $5.75, after a previous close of $6.05. The stock reached a daily high of $7.20 and a low of $5.64, with a 52-week high of $7.25 and a 52-week low of $1.04.

Can Indians buy Cumberland Pharmaceuticals shares?

Yes, Indians can invest in the Cumberland Pharmaceuticals (CPIX) from India.

With INDmoney, you can buy Cumberland Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cumberland Pharmaceuticals at zero transaction cost.

How can I buy Cumberland Pharmaceuticals shares from India?

It is very easy to buy Cumberland Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cumberland Pharmaceuticals (CPIX) be purchased?

Yes, you can buy fractional shares of Cumberland Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Cumberland Pharmaceuticals stocks?

To start investing in Cumberland Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.